Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Dexcom G6 cleared by FDA with no fingerstick calibrations, 10-day wear time, approval for ages 2 years and older, no acetaminophen interference, and more
As early as 2019, the FDA could approve SGLT-2 inhibitors for adults with type 1, but some patients are already using these pills “off label”; see guidance from leading...
Toujeo Max SoloStar will launch later this year in the US. It holds 900 units of insulin and can dose up to 160 units in one injection, meaning fewer refills and...
Ultra-slim patch supports convenient mealtime insulin dosing; wearers just hit two buttons simultaneously to deliver 2 units at a time; acquired by CeQur as J&J...
A unique mindset to resist tempting foods, including in peer-pressured group settings
Experts and innovators from all corners gathered to share the latest in new technology and treatments for people with diabetes, focusing on improving CGM and outcomes...
ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!
Limited launch in May-July. No receiver! Smartphone-only display on Apple iOS devices. Plus, the new “personal diabetes assistant,” Sugar.IQ with Watson
Learn more about DiabetesMine D-Data highlights, implantable CGM Eversense used in adolescents, and Sugar.IQ real-world data
Low-cost education services can help you learn new skills to eat well, stay active, and monitor blood sugar levels
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
FDA clearance and limited US launch expected in the second half of 2018. Dash adds improved user experience, Bluetooth, smartphone viewing, remote monitoring
Smart Patients and diaTribe are partnering to offer an easy and supportive platform to talk about diabetes
Medtronic hopes to launch at least 10 products over the next two years: new CGM and apps, 670G pump with Bluetooth, AI, and more!
The upcoming Basal-IQ predictive low glucose suspend system (summer 2018 launch expected), plus plans for Control-IQ hybrid closed loop, a mobile app, and the t:sport “...
Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more!
Learn more about the All of Us Research Program, a massive national effort to collect individual health data to support precision medicine research
Delays caused by sensor shortages largely resolved; MiniMed 670G now ships as soon as insurance is approved; a new assistance program to help with upfront costs
An app uses blood sugar readings and other diabetes information to provide personalized guidance to workouts, along with exercise videos specifically for people with...
Limited US launch beginning in second half of this year, with full launch in early 2019; Dash PDM Handheld will be free with purchase of pods

Pages